Prolactin ≤1 ng/mL predicts macroprolactinoma reduction after cabergoline therapy
نویسندگان
چکیده
منابع مشابه
Pneumocephalus during cabergoline treatment of an invasive macroprolactinoma.
A 43-year-old male trisomic patient was referred for acute left headache and progressive homolateral mydriasis and ptosis. Computed tomography and T2-magnetic resonance imaging demonstrated a 4 cm invasive pituitary adenoma (Panels A and C, respectively). Blood analyses revealed hyperprolactinemia (5460 ng/ml, normal values < 15 ng/ml) and severe gonadotrophic insuffi ciency. Treatment was clas...
متن کاملA macroprolactinoma becoming resistant to cabergoline and developing atypical pathology
Pituitary adenomas are a common intracranial neoplasm, usually demonstrating a benign phenotype. They can be classified according to pathological, radiological or clinical behaviour as typical, atypical or carcinomas, invasive or noninvasive, and aggressive or nonaggressive. Prolactinomas account for 40-60% of all pituitary adenomas, with dopamine agonists representing the first-line treatment ...
متن کاملChronic cluster‐like headache in a patient with a macroprolactinoma presenting with falsely low prolactin levels: bromocriptine versus cabergoline?
Cluster-like headache may be associated with pituitary tumors, mostly prolactinomas. Pituitary imaging and prolactin measurement should be assessed in patients presenting with cluster-like headaches with atypical features or unsatisfactory response to treatment. Furthermore, large pituitary adenomas with moderate increase in prolactin levels should prompt prolactin dilutions to avoid "hook effe...
متن کاملTension pneumocephalus after administration of two 0.25 mg cabergoline tablets in MEN1-related macroprolactinoma.
To cite: Nanba K, Usui T, Nakakuki T, et al. BMJ Case Rep Published online: [please include Day Month Year] doi:10.1136/bcr-2013009986 DESCRIPTION A 28-year-old man diagnosed with multiple endocrine neoplasia type 1 (MEN1) was referred to us for medical treatment of macroprolactinoma. His serum prolactin level was 8071 ng/mL in diluted sample and brain MRI showed an invasive lobulated giant pit...
متن کاملComparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.
OBJECTIVE It is well known that bromocriptine has a suppressive effect on the prolactin release in hyperprolactinemic patients. But it also has some adverse effects. The new, long-acting dopaminergic drug, cabergoline, has been reported to be an effective agent in these patients. However, there are relatively few reports comparing the beneficial and adverse effects of these drugs in the treatme...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Endocrinology
سال: 2020
ISSN: 0804-4643,1479-683X
DOI: 10.1530/eje-19-0753